These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26990462)
21. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice. Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524 [TBL] [Abstract][Full Text] [Related]
22. Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor α-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells. Liu X; Ma S; Dai C; Cai F; Yao Y; Yang Y; Feng M; Deng K; Li G; Ma W; Xin B; Lian W; Xiang G; Zhang B; Wang R Endocrinology; 2013 Apr; 154(4):1414-23. PubMed ID: 23462961 [TBL] [Abstract][Full Text] [Related]
23. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery. Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742 [TBL] [Abstract][Full Text] [Related]
24. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro. Mizusako H; Tagami T; Hattori K; Ozeki T J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848 [TBL] [Abstract][Full Text] [Related]
25. Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors. Gazzano E; Rolando B; Chegaev K; Salaroglio IC; Kopecka J; Pedrini I; Saponara S; Sorge M; Buondonno I; Stella B; Marengo A; Valoti M; Brancaccio M; Fruttero R; Gasco A; Arpicco S; Riganti C J Control Release; 2018 Jan; 270():37-52. PubMed ID: 29191785 [TBL] [Abstract][Full Text] [Related]
26. Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex. Chiu CC; Lin YT; Sun SL; Sung KH; Wang LF J Biomater Sci Polym Ed; 2011; 22(11):1487-507. PubMed ID: 20626956 [TBL] [Abstract][Full Text] [Related]
27. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay. Zhang C; Wu Y; Dong Y; Xu H; Zhao L Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143 [TBL] [Abstract][Full Text] [Related]
28. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123 [TBL] [Abstract][Full Text] [Related]
29. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. Song H; Su C; Cui W; Zhu B; Liu L; Chen Z; Zhao L Biomed Res Int; 2013; 2013():723158. PubMed ID: 24282819 [TBL] [Abstract][Full Text] [Related]
30. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo. Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976 [TBL] [Abstract][Full Text] [Related]
31. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy. Chen H; Li S; Li B; Ren X; Li S; Mahounga DM; Cui S; Gu Y; Achilefu S Nanoscale; 2012 Sep; 4(19):6050-64. PubMed ID: 22930451 [TBL] [Abstract][Full Text] [Related]
32. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420 [TBL] [Abstract][Full Text] [Related]
33. Targeted Chemo-Phototherapy in Red Light with Novel Doxorubicin and Iron(III) Complex-Functionalized Gold Nanoconjugate (Dox-Fe@FA-AuNPs). Pal M; Bera A; Masarkar N; Upadhyay A; Mukherjee S; Roy M Chem Asian J; 2024 Sep; 19(18):e202400616. PubMed ID: 38923831 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Datir SR; Das M; Singh RP; Jain S Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830 [TBL] [Abstract][Full Text] [Related]
35. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128 [TBL] [Abstract][Full Text] [Related]
36. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. Lu JY; Lowe DA; Kennedy MD; Low PS J Drug Target; 1999; 7(1):43-53. PubMed ID: 10614814 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830 [TBL] [Abstract][Full Text] [Related]
38. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849 [TBL] [Abstract][Full Text] [Related]
39. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
40. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]